Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risks for hyperlipidemia.

A C Nestruck, J Davignon

    Cardiology Clinics
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A PCSK9 variant and familial combined hyperlipidaemia.

    Journal of medical genetics·2008
    Same author

    Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools.

    Journal of internal medicine·2007
    Same author

    Cardioprotective and other emerging effects of statins.

    International journal of clinical practice. Supplement·2005
    Same author

    Advances in lipid-lowering therapy in atherosclerosis.

    Advances in experimental medicine and biology·2002
    Same author

    Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects.

    The American journal of clinical nutrition·2001
    Same author

    Interaction of lecithin:cholesterol acyltransferase (LCAT).alpha 2-macroglobulin complex with low density lipoprotein receptor-related protein (LRP). Evidence for an alpha 2-macroglobulin/LRP receptor-mediated system participating in LCAT clearance.

    The Journal of biological chemistry·2001
    Same journal

    The Heart-Brain Connection.

    Cardiology clinics·2026
    Same journal

    Overcoming Psychological Barriers to Treatment Adherence: The Case of Antihypertensive Medication.

    Cardiology clinics·2026
    Same journal

    Cardio-oncology Rehabilitation and Mental Health: Current Evidence and Future Perspectives.

    Cardiology clinics·2026
    Same journal

    Cardiac Rehabilitation and Mental Health.

    Cardiology clinics·2026
    Same journal

    Best-Practice Mental Health Interventions Following Acute Cardiovascular Events.

    Cardiology clinics·2026
    Same journal

    Positive Psychology Interventions and Cardiovascular Health: Frequency and Duration to Sustain Cardiovascular Benefits.

    Cardiology clinics·2026
    See all related articles

    Genetic and environmental factors equally influence hyperlipidemia risk. This review focuses on long-term genetic, dietary, and drug therapy exposures that increase susceptibility to hyperlipidemia and cardiovascular disease.

    Area of Science:

    • Cardiovascular Medicine
    • Genetics
    • Nutritional Science

    Background:

    • Hyperlipidemia development is influenced by both genetic and environmental factors.
    • The duration of exposure to risk factors is not well understood.
    • Hyperlipidemia is a significant risk factor for cardiovascular disease.

    Purpose of the Study:

    • To review genetic factors contributing to hyperlipidemia.
    • To examine long-term environmental factors, including diet and drug therapies, that increase hyperlipidemia risk.

    Main Methods:

    • Literature review of genetic predispositions.
    • Analysis of long-term environmental risk factors such as diet and drug therapies.

    Main Results:

    Keywords:
    AmericasBiologyCardiovascular EffectsCholesterolContraceptionContraceptive Agents, FemaleDeveloped CountriesDeveloping CountriesDiseasesDrugs--pharmacodynamicsDrugs--side effectsFamily PlanningGeneticsHealthHeart DiseasesIngredients And ChemicalsLipid Metabolic EffectsLipidsLiterature ReviewMetabolic EffectsNorth AmericaNorthern AmericaNutritionOral ContraceptivesOrganic ChemicalsPhysiologySmokingSocial BehaviorTreatmentUnited States

    Related Experiment Videos

  • Genetic factors play a substantial role in hyperlipidemia predisposition.
  • Diet and certain drug therapies are identified as significant long-term environmental risk factors.
  • Understanding exposure duration is crucial for risk assessment.

    • Conclusions:

    • Both genetic and environmental factors are critical in hyperlipidemia development.
    • Long-term exposure to specific diets and medications can elevate hyperlipidemia risk.
    • Further research into exposure duration is needed to refine cardiovascular disease prevention strategies.